Monthly Archives: July 2020

United States Begins Phase 3 Clinical Trial of COVID-19 Vaccine

A phase 3 clinical trial designed to assess whether an investigational vaccine can prevent symptomatic coronavirus disease 2019 (COVID-19) in adults has started. The vaccine, known as mRNA-1273, was jointly developed by Cambridge, Massachusetts-based biotech company Moderna, Inc. and the National Institute of Allergy and Infectious Diseases (NIAID), part of …

Read More »